Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study

Background: Reperfusion can be done through primary percutaneous coronary intervention (PPCI) and thrombolytic administration. Patients with myocardial infarction should receive antiplatelet drugs from the P2Y12 receptor inhibitor category (such as ticagrelor, prasugrel, and clopidogrel). Based on r...

Full description

Bibliographic Details
Main Authors: Salman Nikfarjam, Yasaman Borghei, Arsalan Salari, Seyyed Mehrad Miraftabi, Bahare Gholami-Chaboki, Seyyed Aboozar Fakhr-Moosavi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Research in Cardiovascular Medicine
Subjects:
clopidogrel
myocardial infarction
percutaneous coronary intervention
ticagrelor
Online Access:http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2023;volume=12;issue=2;spage=56;epage=60;aulast=Nikfarjam

Internet

http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2023;volume=12;issue=2;spage=56;epage=60;aulast=Nikfarjam

Similar Items